The Journal of Biomolecules, Pathogenesis and Therapeutics (JBPT) is a quarterly, peer-reviewed, open-access journal dedicated to publishing high-quality, impactful research at the precise interface of biomolecular science, complex cellular disease mechanisms, and therapeutic developments. The journal serves as a premier international forum for deep structural, biochemical, and clinical studies that advance the fundamental molecular understanding of human diseases and actively translate those insights into concrete diagnostic tools, preventive strategies, and target-specific therapeutic applications.
JBPT embraces a vast multidisciplinary scope encompassing comprehensive basic, translational, and clinical investigations. The publication umbrella specifically targets the structural dynamics and systemic functions of key biomolecules—including proteins, nucleic acids, glycans, lipids, and immune mediators—mapping their roles across various infectious, inflammatory, metabolic, genetic, neurodegenerative, and neoplastic disorders.
To comprehensively represent modern milestones across the full spectrum of the basic medical sciences, clinical pathogenesis, molecular medicine, and multi-omics discoveries, the journal welcomes sophisticated investigations across specialized, core, and experimental tracking divisions, including but not limited to:
The journal actively serves molecular biologists, geneticists, biochemists, clinical pathology researchers, immunologists, pharmaceutical scientists, biotechnologists, and healthcare professionals working in specialized fields of translational medicine and targeted diagnostic discovery tracks.
JBPT operates with absolute and full editorial independence while adhering strictly to high ethical publishing standards in accordance with the established principles of the Committee on Publication Ethics (COPE).
